# The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease

> **NCT01157260** · PHASE4 · UNKNOWN · sponsor: **Ewha Womans University** · enrollment: 30 (estimated)

## Conditions studied

- Kidney Failure, Chronic

## Interventions

- **DRUG:** Kremezin

## Key facts

- **NCT ID:** NCT01157260
- **Lead sponsor:** Ewha Womans University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-09
- **Primary completion:** 2011-08
- **Final completion:** 2011-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2010-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01157260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01157260, "The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01157260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*